Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:53 PM
Ignite Modification Date:
2025-12-24 @ 2:53 PM
NCT ID:
NCT06208059
Eligibility Criteria:
Inclusion Criteria:
1. patients with upper limb movement disorders who meet the diagnostic criteria for stroke;
2. 40 years old ≤ age ≤ 75 years old, gender is not limited;
3. head MRI or CT scanning found responsible lesions;
4. first onset of the disease, disease duration of 2 weeks to 6 months, stable condition, stable vital signs, conscious without unconsciousness;
5. upper limb muscle strength on the affected side ≥ grade 3, wrist dorsiflexion muscle strength ≥ grade 2, wrist flexion muscle strength ≥ grade 2;
6. no serious cardiac, pulmonary, or renal impairment;
7. voluntarily participate in this study and sign the informed consent form.
Exclusion Criteria:
1. a previous history of stroke or other brain disease;
2. with severe mental retardation and/or severe aphasia that interferes with communication;
3. with severe cardiac, pulmonary, and renal impairment in an unstable condition;
4. inability to autonomously perform wrist flexion and extension movements on the hemiplegic side;
5. neurological or musculoskeletal diseases affecting the recovery of limb function before the onset of the disease, with pre-existing abnormalities in bilateral wrist movements;
6. allergy to adhesive tape, solid gel, etc.; bleeding tendency, acute suppurative inflammation, combined ulcers, infections, scars and tumors at acupuncture points and nearby areas; installation of pacemakers;
7. transient ischemic attack, rebleeding after infarction, bilateral cerebral infarction, brain stem infarction, excessive cerebral hemorrhage or cranial defect;
8. history of needle fainting or fear of needling.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
75 Years
Study:
NCT06208059
Study Brief:
Protocol Section:
NCT06208059